Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors
Alaunos Therapeutics
Alaunos Therapeutics
Tempus AI
Incyte Corporation
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NextCure, Inc.
pharmaand GmbH
Incyte Corporation
Incyte Corporation
Seagen Inc.
Gilead Sciences
Incyte Corporation
Eisai Inc.
Seagen Inc.
Amgen
INSYS Therapeutics Inc